Manuscripts
Showing 1596 manuscripts.
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial
Citation
Risa M Hoffman, Konstantia Nadia Angelidou, Sean S Brummel, Friday Saidi, Avy Violari, Dingase Dula, Vidya Mave, Lee Fairlie, Gerhard Theron, Moreen Kamateeka, Tsungai Chipato, Benjamin H Chi, Lynda Stranix-Chibanda, Teacler Nematadzira, Dhayendre Moodley, Debika Bhattacharya, Amita Gupta, Anne Coletti, James A McIntyre, Karin L Kingman, Nahida Chakhtoura, David E Shapiro, Mary Glenn Fowler, Judith S Currier, IMPAACT PROMISE 1077BF/FF Team. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clinical Trials. 2018 Dec 01; 19(6):209-224. PMID: 30890061; PMCID: PMC6428202.Year
2018
Journal
HIV Clinical Trials
Study
1077BF, 1077FF
Defining Study Outcomes That Better Reflect Individual Response to Treatment
Citation
Konstantia Angelidou, Paul Palumbo, Jane Lindsey, Avy Violary, Moderndran Archary, Linda Barlow, Brian Claggett, Michael Hughes, Lee-Jen Wei, IMPAACT P1060 Study Team. Defining Study Outcomes That Better Reflect Individual Response to Treatment. Pediatric Infectious Disease Journal. 2018 Mar 06; 37(3):258-262. PMID: 29189677; PMCID: PMC5807218.Year
2018
Journal
Pediatric Infectious Disease Journal
Study
P1060
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Citation
Stein Schalkwijk, Rob Ter Heine, Angela C Colbers, Alwin D R Huitema, Paolo Denti, Kelly E Dooley, Edmund Capparelli, Brookie M Best, Tim R Cressey, Rick Greupink, Frans G M Russel, Mark Mirochnick, David M Burger. A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women. Clinical Pharmacokinetics. 2018 Nov 01; 57(11):1421-1433. PMID: 29520730; PMCID: PMC6182466.Year
2018
Journal
Clinical Pharmacokinetics
Study
P1026S
H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment does not appear to impact HIV-1 DNA genotypes or concentration
Citation
Thor A. Wagner, Hannah C. Huang, Christen E. Salyer, Kelly M. Richardson, Adriana Weinberg, Sharon Nachman, Lisa M. Frenkel. H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment does not appear to impact HIV-1 DNA genotypes or concentration. Journal of Acquired Immune Deficiency Syndromes. 2017 Feb 16; 14(1):7. PMID: 28193244; PMCID: PMC5307755.Year
2017
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1086
Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection
Citation
Andres F. Camacho-Gonzalez , Miriam C. Chernoff, Paige L. Williams, Ann Chahroudi , James M. Oleske , Shirley Traite , Rana Chakraborty, Murli U. Purswani , Mark J. Abzug , IMPAACT P1074 Study Team. Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection. Journal of Pediatric Infectious Disease Society. 2017 Sep 01; 6(3):e22-e29. PMID: 27440505; PMCID: PMC5907850.Year
2017
Journal
Journal of Pediatric Infectious Disease Society
Study
P1074
Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa
Citation
MJ Levin, JC Lindsey, SS Kaplan, W Schimana, J Lawrence, M McNeal, M Bwakura-Dangarembizi, A Ogwu, E Mpabalwani, B Heckman, P Sato, GK Siberry, M Nelson, D Hille, GA Weinberg, A Weinberg for the IMPAACT P1072 team. Safety and Immunogenicity of a Live Attenuated Pentavalent Rotavirus Vaccine in HIV-Exposed Infants With and Without HIV Infection in Africa. AIDS. 2017 Jan 01; 2(31(1)):49-59. PMID: 27662551.Year
2017
Journal
AIDS
Study
P1072
Pharmacokinetics of Darunavir/Ritonavir with Etravirine both twice daily in HIV-infected adolescents and young adults
Citation
Tim Cressey, Ram Yogev, Andrew Wiznia, Rohan Hazra, Patrick Jean-Philippe, Bobbie Graham, Amy Gonzalez, Paula Britto, Vincent Carey, Courtney Fletcher, Edward Acosta for the IMPAACT P1058A team. Pharmacokinetics of Darunavir/Ritonavir with Etravirine both twice daily in HIV-infected adolescents and young adults. Journal of the Pediatric Infectious Diseases Society. 2017 Sep 01; 6(3):294-296. PMID: 27103489.Year
2017
Journal
Journal of the Pediatric Infectious Diseases Society
Study
P1058A
Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.
Citation
Ann Melvin, Lisa Aaron, Grace Montepiedra, William Meyer, Hans Spiegel, William Borkowsky, Mark Abzug, Brookie Best, Marilyn Crain, Peggy Borum, Bobbie Graham, Patty Anthony, Katie Shin, George Siberry for the P1063 study team. Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia. Pediaric Infectious Disease Journal. 2017 Jan 02; 36(1):53-60. PMID: 27749649.Year
2017
Journal
Pediaric Infectious Disease Journal
Study
P1063
Breast Milk and In Utero Transmission of HIV-1 Select for Envelope Variants with Unique Molecular Signatures
Citation
Kyle Nakamura, Laura Heath, Edwin Sobrera, Thomas Wilkinson, Katherine Semrau, Chipepo Kankasa, Nicholas Webb, Benhur Lee, Donald Thea, Louise Kuhn, James Mullins, Grace Aldrovandi. Breast Milk and In Utero Transmission of HIV-1 Select for Envelope Variants with Unique Molecular Signatures. Retrovirology. 2017 Jan 26; 14(1):6. PMID: 28122636; PMCID: PMC5267468.Year
2017
Journal
Retrovirology
Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041
Citation
Bret Zeldow, Soyeon Kim, George McSherry, Mark Cotton, Patrick Jean-Philippe, Avy Violari, Raziya Bobat, Sharon Nachman, Lynne Mofenson, Shabir Madhi, Charles Mitchell. Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041. International Journal of Tuberculosis and Lung Disease. 2017 Jan 01; 21(1):38-45. PMID: 28157463; PMCID: PMC5606242.Year
2017
Journal
International Journal of Tuberculosis and Lung Disease
Study
P1041